MAP® Facts

MAP™ – Physicians’ Reference Summary

DESCRIPTION

MAP™ (Master Amino Acid Pattern®) is a dietary protein substitute that delivers a patented blend of essential amino acids in a highly purified, free crystalline form. Supplied in 1,000 mg tablets, MAP™ requires no enzymatic digestion and is fully absorbed within 23 minutes via the first 100 cm of the small intestine.

  • U.S. Patent No. 5,132,113

  • Form: Oral tablets (1,000 mg each)

  • Composition: 100% MAP™ — no fillers, binders, or additives

  • Fecal Residue: None

  • Amphoteric: Functions in both acidic and basic environments

COMPOSITION

Each tablet contains only the active ingredient:
MAP™ – Master Amino Acid Pattern®
A unique, purified combination of essential amino acids.

CLINICAL STUDIES

Multiple double-blind, triple- and quintuple-crossover studies have shown:

  • 99% Net Nitrogen Utilization® (NNU®) – Nearly all amino acids are used for body protein synthesis.

  • Only 1% Waste – Minimal nitrogen catabolites and energy byproducts.

  • Superior Efficiency – Compared to an average of 32% NNU® for dietary proteins.

  • Low Caloric Impact – 400 mg/kg/day (ideal weight) of MAP™ maintains nitrogen balance at <2 kcal/day.

In clinical settings, MAP™ has been used as the sole source of protein, replacing traditional dietary proteins with far greater efficiency and virtually no metabolic waste.

PROTEIN METABOLISM COMPARISON

Characteristic

MAP™

Dietary Proteins

Protein Supplements

Net Nitrogen Utilization (NNU®)

99%

32% (avg)

16% (avg)

Digestion Time

23 minutes

3–6 hours

3–6 hours

BPS Efficiency (NNU®/min)

99% / 23 min

24–48× lower

48–96× lower

Nitrogen Catabolites Released

1%

68% (avg)

84% (avg)

Calories

0.04 kcal/g

4 kcal/g

4 kcal/g

Fecal Residue

Absent

Present

Present

Adverse Reactions

None

Possible food sensitivities

Possible food sensitivities

Contraindications

None

Renal/Hepatic Failure

Renal/Hepatic Failure

Refrigeration

Not needed

Often required

N/A

 

INDICATIONS & USAGE

MAP™ is indicated as a safe and effective substitute for dietary proteins in clinical, athletic, and general nutrition contexts. It is suitable for individuals with dietary restrictions or requiring high-efficiency protein intake.

DOSAGE & ADMINISTRATION

MAP™ is best taken with food. For use as a complete dietary protein substitute, the recommended dose is:

400 mg per kg of ideal body weight per day
Example: To replace 10 g of protein:

  • MAP™ dosage = 10 g × 0.4 = 4 g MAP™ (4 tablets)

Do not exceed 10 tablets within any 2-hour period. Gradually increase dosage if more than 10 tablets per day are needed.

SAFETY PROFILE

  • Adverse Reactions: None reported

  • Overdose: No known risk

  • Contraindications: None

  • Interactions: None known with food or medication

SUPPLY DETAILS

  • Form: Tablets, 1,000 mg

  • Bottle Size: 120 tablets

  • Shelf Life: 3 years

  • Storage: Room temperature; no refrigeration required

IMPORTANT NOTICE

This information is provided for professional reference. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before making changes to your diet or supplement regimen.

For additional medical or clinical information, contact the International Nutrition Research Center